HISA drug rules take effect
A flurry of dueling press releases heralded the onset Monday of the Horseracing Integrity and Safety Authority’s (HISA) new drug rules.
A flurry of dueling press releases heralded the onset Monday of the Horseracing Integrity and Safety Authority’s (HISA) new drug rules.
The Federal Trade Commission on Monday disapproved the proposed HISA drug rules because of ongoing legal uncertainty over the program.
Citing a court ruling that the Horseracing Integrity and Safety Act (HISA) is unconstitutional, ARCI has called for a delay in rules set for Jan. 1.
With the Horseracing Integrity and Safety Act (HISA) recently found unconstitutional, one Senator is pushing a legislative fix, but not everyone’s happy.
Likening racing to a “small town” where people talk about each other, industry insiders called for unified efforts at improvement at the ARCI conference.
The head of the new federal Horseracing Integrity and Safety Authority (HISA) asked state regulators to “just give us a chance” at a conference Monday.
Bob Baffert has a cancel culture problem. Ed Martin has a Bob Baffert problem. Donald Trump has all kinds of problems. What’s going on this Preakness week?
The Association of Racing Commissioners International (ARCI) has taken no position on the proposed federal racing bill, saying too much remains unknown.
The latest data from the Association of Racing Commissioners International (ARCI) indicate that most “positives” are overages of permitted medications.
The Association of Racing Commissioners International (ARCI) backs enhanced and renewed regs on certain medications.